• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量细胞减灭术后肝静脉闭塞病的防治

Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapy.

作者信息

Richardson P, Bearman S I

机构信息

Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver 80262, USA.

出版信息

Leuk Lymphoma. 1998 Oct;31(3-4):267-77. doi: 10.3109/10428199809059219.

DOI:10.3109/10428199809059219
PMID:9869190
Abstract

Venocclusive disease of the liver (VOD) is one of the most common and serious complications following stem cell transplantation. High-dose chemotherapy or chemoradiotherapy injures the structures of Zone 3 of the liver acinus and produces the clinical syndrome of hepatomegaly or right upper quadrant pain, jaundice, and fluid retention. VOD occurs in up to 54% of stem cell transplant recipients and is fatal in 25-50% of them. While the clinical signs of VOD usually manifest during the first post-transplant week, late presentation can occur. The purpose of this review is to discuss the manifestations and pathophysiology of VOD and the options for prevention and treatment.

摘要

肝静脉闭塞病(VOD)是干细胞移植后最常见且严重的并发症之一。大剂量化疗或放化疗会损伤肝腺泡3区的结构,并引发肝肿大或右上腹疼痛、黄疸和液体潴留等临床综合征。高达54%的干细胞移植受者会发生VOD,其中25%-50%会因此死亡。虽然VOD的临床症状通常在移植后的第一周出现,但也可能出现延迟表现。本综述的目的是讨论VOD的表现、病理生理学以及预防和治疗方案。

相似文献

1
Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapy.大剂量细胞减灭术后肝静脉闭塞病的防治
Leuk Lymphoma. 1998 Oct;31(3-4):267-77. doi: 10.3109/10428199809059219.
2
Hepatic veno-occlusive disease following hematopoietic stem cell transplantation.造血干细胞移植后肝静脉闭塞病
Acta Haematol. 2001;106(1-2):57-68. doi: 10.1159/000046590.
3
Veno-occlusive disease in hematopoietic stem cell transplantation recipients.造血干细胞移植受者的静脉闭塞性疾病
Clin J Oncol Nurs. 2012 Oct;16(5):507-13. doi: 10.1188/12.CJON.507-513.
4
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.BCSH/BSBMT 指南:造血干细胞移植后静脉闭塞病(窦状隙阻塞综合征)的诊断和治疗。
Br J Haematol. 2013 Nov;163(4):444-57. doi: 10.1111/bjh.12558. Epub 2013 Sep 17.
5
Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.自体外周干细胞移植后迟发性肝静脉闭塞病经口服去纤苷成功治疗
J Cancer Res Ther. 2009 Oct-Dec;5(4):312-4. doi: 10.4103/0973-1482.59910.
6
Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.去纤维肽治疗造血干细胞移植后儿童肝静脉闭塞病。
Expert Rev Hematol. 2012 Jun;5(3):291-302. doi: 10.1586/ehm.12.18.
7
Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation.大剂量化疗和干细胞移植后迟发性静脉闭塞性疾病
Bone Marrow Transplant. 1999 Oct;24(8):891-5. doi: 10.1038/sj.bmt.1701994.
8
[Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].[窦性阻塞疾病(SOS),既往肝静脉闭塞病(VOD)——造血干细胞移植后仍严重的并发症]
Przegl Lek. 2008;65(4):203-8.
9
Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.韩国患者异基因骨髓移植(BMT)后发生的肝静脉闭塞病(VOD):重组人组织型纤溶酶原激活剂(rt-PA)治疗的疗效
J Korean Med Sci. 1996 Apr;11(2):118-26. doi: 10.3346/jkms.1996.11.2.118.
10
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: review and update on the use of defibrotide.造血干细胞移植后肝静脉闭塞病:去纤苷使用的综述与更新
Semin Thromb Hemost. 2007 Jun;33(4):373-88. doi: 10.1055/s-2007-976173.

引用本文的文献

1
A Retrospective Analysis of Antithrombin III Replacement Therapy for the Treatment of Hepatic Sinusoidal Obstruction Syndrome in Children Following Hematopoietic Stem Cell Transplantation.造血干细胞移植后儿童肝窦阻塞综合征抗凝血酶III替代治疗的回顾性分析
J Pediatr Hematol Oncol. 2020 Mar;42(2):145-148. doi: 10.1097/MPH.0000000000001422.
2
Defibrotide in the treatment of hepatic veno-occlusive disease.去纤苷治疗肝静脉闭塞性疾病
Hepat Med. 2016 Oct 31;8:105-113. doi: 10.2147/HMER.S79243. eCollection 2016.
3
Incidence and management of hepatic severe veno-occlusive disease in 273 patients in a single centre with defibrotide.
单中心273例接受去纤苷治疗患者的肝重度静脉闭塞病的发病率及管理
Bone Marrow Transplant. 2016 Sep;51(9):1262-4. doi: 10.1038/bmt.2016.99. Epub 2016 Apr 25.
4
Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation.乙酰肝素酶基因多态性:对接受异基因造血干细胞移植的儿童肝窦阻塞综合征发生率的影响
J Cancer Res Clin Oncol. 2015 May;141(5):877-85. doi: 10.1007/s00432-014-1857-2. Epub 2014 Oct 22.
5
Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias.支持去纤苷治疗多发性骨髓瘤和其他肿瘤的临床前研究。
Clin Cancer Res. 2009 Feb 15;15(4):1210-21. doi: 10.1158/1078-0432.CCR-08-1270.
6
Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis.纤溶酶原激活物抑制剂-1在小鼠肝静脉血栓形成模型中的关键作用
Blood. 2006 Jan 1;107(1):132-4. doi: 10.1182/blood-2005-07-2681. Epub 2005 Sep 13.